NASDAQ: SSKN
Strata Skin Sciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for SSKN

Based on 1 analyst offering 12 month price targets for Strata Skin Sciences Inc

Min Forecast
$6.00+124.13%
Avg Forecast
$6.00+124.13%
Max Forecast
$6.00+124.13%

Should I buy or sell SSKN stock?

Based on 1 analyst offering ratings for Strata Skin Sciences Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SSKN stock forecasts and price targets.

SSKN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-02-27

1 of 1

Forecast return on equity

Is SSKN forecast to generate an efficient return?

Company
-32.72%
Industry
20.08%
Market
76.96%
SSKN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SSKN forecast to generate an efficient return on assets?

Company
-4.5%
Industry
10.81%
SSKN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SSKN earnings per share forecast

What is SSKN's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$1.15
Avg 2 year Forecast
-$0.39

SSKN vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
SSKN$2.68$6.00+124.13%Strong Buy
PAVM$0.66$19.50+2,877.10%Buy
CODX$0.36$1.00+181.69%Hold
BSGM$0.53$2.50+368.16%Buy
VVOS$2.20$6.10+177.27%Strong Buy

Strata Skin Sciences Stock Forecast FAQ

Is Strata Skin Sciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SSKN) stock is to Strong Buy SSKN stock.

Out of 1 analyst, 1 (100%) are recommending SSKN as a Strong Buy, 0 (0%) are recommending SSKN as a Buy, 0 (0%) are recommending SSKN as a Hold, 0 (0%) are recommending SSKN as a Sell, and 0 (0%) are recommending SSKN as a Strong Sell.

If you're new to stock investing, here's how to buy Strata Skin Sciences stock.

What is SSKN's earnings growth forecast for 2025-2026?

(NASDAQ: SSKN) Strata Skin Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 52.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 71.14%.

Strata Skin Sciences's earnings in 2025 is -$10,086,000.On average, 1 Wall Street analyst forecast SSKN's earnings for 2025 to be -$4,796,835, with the lowest SSKN earnings forecast at -$4,796,835, and the highest SSKN earnings forecast at -$4,796,835.

In 2026, SSKN is forecast to generate -$1,626,753 in earnings, with the lowest earnings forecast at -$1,626,753 and the highest earnings forecast at -$1,626,753.

What is SSKN's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: SSKN) forecast ROE is -32.72%, which is considered weak.

What is SSKN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SSKN price target, the average SSKN price target is $6.00, with the highest SSKN stock price forecast at $6.00 and the lowest SSKN stock price forecast at $6.00.

The Wall Street analyst predicted that Strata Skin Sciences's share price could reach $6.00 by Feb 27, 2026. The average Strata Skin Sciences stock price prediction forecasts a potential upside of 124.13% from the current SSKN share price of $2.68.

What is SSKN's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: SSKN) Strata Skin Sciences's current Earnings Per Share (EPS) is -$2.65. On average, analysts forecast that SSKN's EPS will be -$1.15 for 2025, with the lowest EPS forecast at -$1.15, and the highest EPS forecast at -$1.15. In 2026, SSKN's EPS is forecast to hit -$0.39 (min: -$0.39, max: -$0.39).

What is SSKN's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: SSKN) forecast ROA is -4.5%, which is lower than the forecast US Medical Devices industry average of 10.81%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.